edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
BiondVax (Nasdaq: BVXV) is a biopharmaceutical company focused on developing, manufacturing and commercialising innovative products for the prevention and treatment of infectious diseases and other illnesses. It is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases such as COVID-19, asthma and psoriasis.
In this interview, Dalit Weinstein Fischer, head of Technical R&D at BiondVax, discusses the company’s NanoAb development process and BiondVax’s GMP manufacturing facility.
Get access to the very latest content matched to your personal investment style.